UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

Leukemia, 2017-12, Vol.31 (12), p.2642-2651

2017

Volltextzugriff (PDF)

Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (20), p.7669-7674

2001

Volltextzugriff (PDF)

Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer

Clinical cancer research, 2000-12, Vol.6 (12), p.4628-4634

2000

Volltextzugriff (PDF)

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development

Vaccine, 2000-12, Vol.19 (9), p.1294-1303

2000

Volltextzugriff (PDF)

Enhancement of Vincristine Cytotoxicity in Drug-Resistant Cells by Simultaneous Treatment With Onconase, an Antitumor Ribonuclease

JNCI : Journal of the National Cancer Institute, 1996-06, Vol.88 (11), p.747-753

1996

Volltextzugriff (PDF)

Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis

The American journal of pathology, 1997-05, Vol.150 (5), p.1869-1880

1997

Volltextzugriff (PDF)

Zinc ligand-disrupted recombinant human endostatin : Potent inhibition of tumor growth, safety and pharmacokinetic profile

Angiogenesis (London), 1999, Vol.3 (1), p.41-51

1999

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2003-01, Vol.21 (2), p.223-231

2003

Volltextzugriff (PDF)

Synthesis and Enantiomeric Separation of 2-Phthalimidino-glutaric Acid Analogues: Potent Inhibitors of Tumor Metastasis

Journal of medicinal chemistry, 1999-08, Vol.42 (16), p.3014-3017

1999

Volltextzugriff (PDF)

NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction

The Journal of immunology (1950), 1996-06, Vol.156 (12), p.4707-4714

1996

Volltextzugriff (PDF)

The Tumor-Suppressing Activity of Angiostatin Protein Resides within Kringles 1 to 3

Biochemical and biophysical research communications, 1999-10, Vol.264 (2), p.469-477

1999

Volltextzugriff (PDF)

Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase

The Journal of immunology (1950), 1997-11, Vol.159 (9), p.4187-4196

1997

Volltextzugriff (PDF)

Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells

Cancer gene therapy, 2004-05, Vol.11 (5), p.346-353

2004

Volltextzugriff (PDF)

Enhancement by Recombinant Human Interferon Alfa of the Reversal of Multidrug Resistance by MRK-16 Monoclonal Antibody

JNCI : Journal of the National Cancer Institute, 1995-01, Vol.87 (2), p.94-103

1995

Volltextzugriff (PDF)

Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas

The Journal of immunology (1950), 1998-12, Vol.161 (11), p.6014-6021

1998

Volltextzugriff (PDF)

Intradermal Delivery of IL-12 Naked DNA Induces Systemic NK Cell Activation and Th1 Response In Vivo That Is Independent of Endogenous IL-12 Production

The Journal of immunology (1950), 1999-08, Vol.163 (4), p.1943-1950

1999

Volltextzugriff (PDF)

Eradication of Spontaneous Metastases and Activation of Alveolar Macrophages by Intravenous Injection of Liposomes Containing Muramyl Dipeptide

Proceedings of the National Academy of Sciences - PNAS, 1981-03, Vol.78 (3), p.1680-1684

1981

Volltextzugriff (PDF)

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3772-3784

2002

Volltextzugriff (PDF)

Generation of a Specific Immunological Response to FGF-2 Does Not Affect Wound Healing or Reproduction

Immunopharmacology and immunotoxicology, 2004-01, Vol.26 (1), p.29-41

2004

Volltextzugriff (PDF)

Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators

Cancer research (Chicago, Ill.), 1982-02, Vol.42 (2), p.496-501

1982

Volltextzugriff (PDF)

Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes

The Journal of immunology (1950), 1985-12, Vol.135 (6), p.4289-4296

1985

Volltextzugriff (PDF)

Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody

JNCI : Journal of the National Cancer Institute, 1991-10, Vol.83 (19), p.1386-1391

1991

Volltextzugriff (PDF)

The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction

The Journal of immunology (1950), 1986-03, Vol.136 (6), p.2311-2317

1986

Volltextzugriff (PDF)

IL-7 activates alpha4beta1 integrin in murine thymocytes

The Journal of immunology (1950), 1997-09, Vol.159 (5), p.2259-2264

1997

Volltextzugriff (PDF)

Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages

Cancer research (Chicago, Ill.), 1980-12, Vol.40 (12), p.4460-4466

1980

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(153)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model

Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development

Enhancement of Vincristine Cytotoxicity in Drug-Resistant Cells by Simultaneous Treatment With Onconase, an Antitumor Ribonuclease

Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis

Zinc ligand-disrupted recombinant human endostatin : Potent inhibition of tumor growth, safety and pharmacokinetic profile

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

Synthesis and Enantiomeric Separation of 2-Phthalimidino-glutaric Acid Analogues: Potent Inhibitors of Tumor Metastasis

NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction

The Tumor-Suppressing Activity of Angiostatin Protein Resides within Kringles 1 to 3

Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase

Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells

Enhancement by Recombinant Human Interferon Alfa of the Reversal of Multidrug Resistance by MRK-16 Monoclonal Antibody

Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas

Intradermal Delivery of IL-12 Naked DNA Induces Systemic NK Cell Activation and Th1 Response In Vivo That Is Independent of Endogenous IL-12 Production

Eradication of Spontaneous Metastases and Activation of Alveolar Macrophages by Intravenous Injection of Liposomes Containing Muramyl Dipeptide

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

Generation of a Specific Immunological Response to FGF-2 Does Not Affect Wound Healing or Reproduction

Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators

Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes

Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody

The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction

IL-7 activates alpha4beta1 integrin in murine thymocytes

Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages

Suchergebnisse filtern